Generac Holdings Inc. (GNRC) Stock Forecast
Data as of Jul 31, 2026Industrials · Current price $199.30 (+3.69%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 27, 2026 | Christine Cho | Barclays | $228.00 | +14.4% |
| Feb 13, 2026 | Jon Windham | UBS | $270.00 | +35.5% |
| Feb 12, 2026 | Michael Halloran | Robert W. Baird | $292.00 | +46.5% |
| Oct 30, 2025 | Chip Moore | Roth Capital | $184.00 | -7.7% |
| Jul 31, 2025 | Jon Windham | UBS | $220.00 | +10.4% |
| Oct 31, 2024 | Stephen Gengaro | Stifel Nicolaus | $175.00 | -12.2% |
| Oct 31, 2024 | Jordan Levy | Truist Financial | $210.00 | +5.4% |
| Oct 31, 2024 | Jerry Revich | Goldman Sachs | $148.00 | -25.7% |
| Oct 21, 2024 | Vikram Bagri | Citigroup | $172.00 | -13.7% |
| Sep 24, 2024 | Kashy Harrison | Piper Sandler | $175.00 | -12.2% |
| Aug 1, 2024 | George Gianarikas | Canaccord Genuity | $200.00 | +0.4% |
| May 23, 2024 | Jordan Levy | Truist Financial | $170.00 | -14.7% |
| May 2, 2024 | Christopher Glynn | Oppenheimer | $145.00 | -27.2% |
| Apr 23, 2024 | Chip Moore | Roth Capital | $135.00 | -32.3% |
| Apr 5, 2024 | George Giankarikas | Canaccord Genuity | $150.00 | -24.7% |
| Feb 7, 2024 | Strong Buy | CFRA | $145.00 | -27.2% |
| Aug 4, 2023 | Jordan Levy | Truist Financial | $160.00 | -19.7% |
| Feb 16, 2023 | George Giankarikas | Canaccord Genuity | $175.00 | -12.2% |
| Dec 28, 2022 | Sean Milligan | Janney Montgomery | $160.00 | -19.7% |
| Oct 20, 2022 | Philip Shen | Roth Capital | $75.00 | -62.4% |
Top Analysts Covering GNRC
GNRC vs Sector & Market
| Metric | GNRC | Industrials Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.32 | 2.40 | 2.42 |
| Analyst Count | 28 | 8 | 19 |
| Target Upside | +49.7% | +109.0% | +18.0% |
| P/E Ratio | 62.48 | 36.59 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4.68B | $4.84B | $4.89B | 14 |
| 2027-12-31 | $5.22B | $5.43B | $5.62B | 14 |
| 2028-12-31 | $6.10B | $6.12B | $6.14B | 9 |
| 2029-03-31 | $1.49B | $1.53B | $1.56B | 6 |
| 2029-06-30 | $1.60B | $1.64B | $1.68B | 8 |
| 2029-09-30 | $1.69B | $1.73B | $1.77B | 5 |
| 2029-12-31 | $1.73B | $1.77B | $1.81B | 5 |
| 2030-03-31 | $1.71B | $1.75B | $1.79B | 7 |
| 2030-06-30 | $1.78B | $1.83B | $1.88B | 9 |
| 2030-09-30 | $1.81B | $1.86B | $1.90B | 5 |
| 2030-12-31 | $1.86B | $1.91B | $1.96B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $8.06 | $8.44 | $8.96 | 13 |
| 2027-12-31 | $9.35 | $10.42 | $11.36 | 13 |
| 2028-12-31 | $10.25 | $12.85 | $14.55 | 6 |
| 2029-03-31 | $2.89 | $2.99 | $3.08 | 10 |
| 2029-06-30 | $3.50 | $3.62 | $3.74 | 9 |
| 2029-09-30 | $4.08 | $4.21 | $4.35 | 9 |
| 2029-12-31 | $4.21 | $4.35 | $4.49 | 10 |
| 2030-03-31 | $3.75 | $3.88 | $4.00 | 5 |
| 2030-06-30 | $3.88 | $4.01 | $4.14 | 5 |
| 2030-09-30 | $4.23 | $4.38 | $4.51 | 5 |
| 2030-12-31 | $4.32 | $4.46 | $4.61 | 5 |
Frequently Asked Questions
What is the analyst consensus for GNRC?
The consensus among 28 analysts covering Generac Holdings Inc. (GNRC) is Buy with an average price target of $297.20.
What is the highest price target for GNRC?
The highest price target for GNRC is $555.00, set by Philip Shen at Roth Capital on 2021-11-03.
What is the lowest price target for GNRC?
The lowest price target for GNRC is $75.00, set by Philip Shen at Roth Capital on 2022-10-20.
How many analysts cover GNRC?
28 analysts have issued ratings for Generac Holdings Inc. in the past 12 months.
Is GNRC a buy or sell right now?
Based on 28 analyst ratings, GNRC has a consensus rating of Buy (2.32/5) with a +49.7% upside to the consensus target of $297.20.
What are the earnings estimates for GNRC?
Analysts estimate GNRC will report EPS of $8.44 for the period ending 2026-12-31, with revenue estimated at $4.84B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.